Literature DB >> 15269202

Role of MAPK phosphatase-1 (MKP-1) in adipocyte differentiation.

Hiroshi Sakaue1, Wataru Ogawa, Takehiro Nakamura, Toshiyuki Mori, Kyoko Nakamura, Masato Kasuga.   

Abstract

Both time-dependent modulation of intracellular signaling molecules and sequential induction of transcriptional regulators are essential for the differentiation of preadipocytes into adipocytes. We have now shown that the activity, but not the abundance, of p42/p44 mitogen-activated protein kinase (MAPK) is down-regulated during adipocyte differentiation. This decrease in p42/p44 MAPK activity does not appear to be a direct effect of hormonal inducers of differentiation but rather represents a characteristic event of adipocyte differentiation that is achieved through a persistent change in intracellular signaling. Although the phosphorylation or abundance of MEK, an upstream kinase for p42/p44 MAPK, was not altered during differentiation, the abundance of MAPK phosphatase-1 (MKP-1), a negative regulator of p42/p44 MAPK, was increased with a time course similar to that of the down-regulation of p42/p44 MAPK activity. Ectopic expression of MKP-1 in preadipocytes reduced and depletion of endogenous MKP-1 in mature adipocytes increased the activity of p42/p44 MAPK. Prevention of the up-regulation of MKP-1 abundance in preadipocytes by expression of Mkp-1 antisense RNA resulted in persistence of p42/p44 MAPK activation and blocked differentiation, effects that were reversed by the MEK inhibitor PD98059. These results suggest that MKP-1 plays an essential role in adipocyte differentiation through down-regulation of p42/p44 MAPK activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15269202     DOI: 10.1074/jbc.M407353200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Overexpression of the dual-specificity phosphatase MKP-4/DUSP-9 protects against stress-induced insulin resistance.

Authors:  Brice Emanuelli; Delphine Eberlé; Ryo Suzuki; C Ronald Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-22       Impact factor: 11.205

Review 2.  Mitogen-Activated Protein Kinase Phosphatase (MKP)-1 in Nervous System Development and Disease.

Authors:  Louise M Collins; Eric J Downer; André Toulouse; Yvonne M Nolan
Journal:  Mol Neurobiol       Date:  2014-06-24       Impact factor: 5.590

Review 3.  Mitogen-activated protein kinase phosphatase-1 - a potential therapeutic target in metabolic disease.

Authors:  Rachel J Roth Flach; Anton M Bennett
Journal:  Expert Opin Ther Targets       Date:  2010-12       Impact factor: 6.902

4.  Expression Profiling of the MAP Kinase Phosphatase Family Reveals a Role for DUSP1 in the Glioblastoma Stem Cell Niche.

Authors:  Bradley N Mills; George P Albert; Marc W Halterman
Journal:  Cancer Microenviron       Date:  2017-08-18

5.  Core erythropoietin receptor signals for late erythroblast development.

Authors:  Madhu P Menon; Jing Fang; Don M Wojchowski
Journal:  Blood       Date:  2005-12-06       Impact factor: 22.113

Review 6.  Mitogen-activated protein kinase phosphatase (MKP)-1 in immunology, physiology, and disease.

Authors:  Lyn M Wancket; W Joshua Frazier; Yusen Liu
Journal:  Life Sci       Date:  2011-12-13       Impact factor: 5.037

7.  Iron-dependent regulation of MDM2 influences p53 activity and hepatic carcinogenesis.

Authors:  Paola Dongiovanni; Anna Ludovica Fracanzani; Gaetano Cairo; Chiara Paola Megazzini; Stefano Gatti; Raffaela Rametta; Silvia Fargion; Luca Valenti
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

8.  Inhibition of adipocyte differentiation by phytoestrogen genistein through a potential downregulation of extracellular signal-regulated kinases 1/2 activity.

Authors:  Qing-Chuan Liao; Ya-Lin Li; Yan-Fang Qin; L Darryl Quarles; Kang-Kang Xu; Rong Li; Hong-Hao Zhou; Zhou-Sheng Xiao
Journal:  J Cell Biochem       Date:  2008-08-01       Impact factor: 4.429

9.  Mitogen-activated protein kinase phosphatase 1/dual specificity phosphatase 1 mediates glucocorticoid inhibition of osteoblast proliferation.

Authors:  Kay Horsch; Heidi de Wet; Macé M Schuurmans; Fatima Allie-Reid; Andrew C B Cato; John Cunningham; Jacky M Burrin; F Stephen Hough; Philippa A Hulley
Journal:  Mol Endocrinol       Date:  2007-08-30

10.  Regulation of early adipose commitment by Zfp521.

Authors:  Sona Kang; Peter Akerblad; Riku Kiviranta; Rana K Gupta; Shingo Kajimura; Michael J Griffin; Jie Min; Roland Baron; Evan D Rosen
Journal:  PLoS Biol       Date:  2012-11-27       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.